Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a clinical condition characterized by pulmonary arterial remodeling and vasoconstriction, which promote chronic vessel obstruction and elevation of pulmonary vascular resistance. Long-term right ventricular (RV) overload leads to RV dysfunction and failure, w...
Saved in:
Main Authors: | Allan K. N. Alencar (Author), Guilherme C. Montes (Author), Eliezer J. Barreiro (Author), Roberto T. Sudo (Author), Gisele Zapata-Sudo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adenosine A2A receptor agonist prevents cardiac remodeling and dysfunction in spontaneously hypertensive male rats after myocardial infarction
by: da Silva JS, et al.
Published: (2017) -
Novel Agonists of Adenosine Receptors in Animal Model of Acute Myocardial Infarction
by: Beltrame F, et al.
Published: (2024) -
Novel p38 Mitogen-Activated Protein Kinase Inhibitor Reverses Hypoxia-Induced Pulmonary Arterial Hypertension in Rats
by: Grazielle Fernandes Silva, et al.
Published: (2022) -
Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
by: Allan K. N. Alencar, et al.
Published: (2018) -
Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis
by: Elizabeth A. Vecchio, et al.
Published: (2017)